COMET AFT-25
Breast Cancer
Comparing an Operative to Monitoring and Endocrine Therapy (COMET)Trial for low risk DCIS: A Phase III Prospective Randomized Trial.
Key Team Members
Principal Investigator
Research Coordinator
Katherine "Kate" Madden
Breast Cancer
Comparing an Operative to Monitoring and Endocrine Therapy (COMET)Trial for low risk DCIS: A Phase III Prospective Randomized Trial.
Katherine "Kate" Madden

